Treatment of chronic renal failure
113 results
1 - 100
Treatment of chronic renal failure - Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- Anaemia of chronic disease (ACD)
- Erythropoietin for chronic renal failure anaemia
- Chronic heart failure
- Hypocalcaemia, hypoparathyroidism and vitamin D deficiency
- Growth hormone for children with chronic renal failure
- Glomerulonephrites
- Acute kidney injury
- Organ transplant recipient in primary health care
- Hyperglycaemic hyperosmolar syndrome
- Curable causes of memory-related symptoms and diseases
- Eye symptoms and signs of systemic diseases
- IgA nephropathy
No benefit to addition of stenting for treatment of atherosclerotic renal artery stenosis- Secondary hypertension
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis New search for studies and content updated (no change to conclusions)- SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status
- Increased blood creatinine concentration, eGFR and renal function tests
- Skin colour changes and pigmentary disorders
- Renal cysts
- High-dose B-vitamins harmful to patients with diabetic nephropathy
- Gout and pseudogout
- Cirrhosis of the liver
- Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease: Cochrane systematic review
- Aliskiren not beneficial for chronic heart failure (ATMOSPHERE)
- ARB treatment of high CV risk patients
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- Gestational hypertension (pre-eclampsia)
- Finerenone decreases hospitalization for heart failure in patients with type 2 diabetes and chronic kidney disease (NNT = 189/year)
- Hyperkalaemia
- Endovascular versus open surgical repair for complicated chronic Type B aortic dissection New
- Tumours of haematopoietic and lymphoid tissues: general information
- Diabetic kidney disease (diabetic nephropathy)
- Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia New search for studies and content updated (no change to conclusions)
- Dronedarone in the prevention of atrial fibrillation - Image
- Low-dose oral = high-dose IV steroids for initial treatment of acute COPD exacerbation
- Pruritus
- IV iron improves symptoms in chronic heart failure patients with iron deficiency
- Obstipation in the adult
- Drugs commonly causing poisonings
- Schistosomiasis (bilharziasis)
- Nephrotic syndrome
- Statins for improving renal outcomes
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Erythropoiesis‐stimulating agents for anaemia in chronic heart failure patients Edited (no change to conclusions)
- Systemic diseases in pregnancy
- Interventions for managing taste disturbances New search for studies and content updated (conclusions changed)
- Improved mortality with early initiation of RRT in critically ill patients
- Hypertension in elderly patients
- Rosuvastatin does not improve outcomes in HF with average lipids
- More evidence against antibiotics for acute asthma exacerbations
- Benzodiazepines for the relief of breathlessness in advanced malignant and non‐malignant diseases in adults Stable (no update expected for reasons given in 'What's new')
- Higher hemoglobin target with epoeitin alfa is harmful in CKD (CHOIR)
- Oral antidiabetic drugs and GLP-1 analogues
- SGLT-2 inhibitors in type 2 diabetes
- Hypoglycaemia in the absence of diabetes in adults
- Statins for people with chronic kidney disease not requiring dialysis
- SBP of 120 instead of 140 in nondiabetic, high-risk elderly leads to significant benefits and some harms (SPRINT)
- Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants Edited (no change to conclusions)
- Antitubercular medication in ambulatory care
- Palliative treatment
- Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants Edited (no change to conclusions)
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Interventions for metabolic bone disease in children with chronic kidney disease New search for studies and content updated (no change to conclusions)
- Antiplatelet agents for chronic kidney disease New search for studies and content updated (no change to conclusions)
- Antidepressants for depression in physical illness
- Normal and abnormal growth in childhood
- Urinary tract infections
- Nipple discharge and mastitis in a non-lactating woman
- Oral adsorbents for preventing or delaying the progression of chronic kidney disease: Cochrane systematic review
- Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis New
- Preoperative assessment
- Non-immunosuppressive treatment for IgA nephropathy: Cochrane systematic review
- Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura New
- Blood pressure targets in adults with hypertension New search for studies and content updated (conclusions changed)
- High-dose barium enemas prevent recurrent diverticular bleeding
- Leg oedema
- Guidelines for when to consider mortality-reducing treatments for patients with type 2 diabetes
- Immunosuppressive T‐cell antibody induction for heart transplant recipients New